Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    VolitionRx

    MCap

    USD58m

    Last close

    USD0.62

    ▲ −0.06 (−8.28%)

    Creotech Instruments

    MCap

    PLN346m

    Last close

    PLN174.00

    ▲ 0.00 (0.00%)

    Creo Medical

    MCap

    GBP79m

    Last close

    GBP0.19

    ▲ −0.25 (−1.30%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Sparks commentary

TMT

Sparks

Brave Bison (LSE: BBSN) points to full-year upgrades
Published by Fiona Orford-Williams

Brave Bison’s first-half results show the effect on revenue of pulling away from less profitable North American business and the consequent improvement in adjusted EBITDA margins. With increased operational leverage on a lower fixed cost base, the group now expects to outstrip broker expectations for the full year, helped further by good new client wins. With a cash-positive balance sheet and a cashflow weighting to the second half, Brave Bison still has ambitions on the M&A front, having walked away from its earlier approach to Mission Group, and has the funding to continue developing its own AI-driven tools to enhance its offering.

Next Sparks Commentary in this sector >

Latest

Healthcare | Comment

BioArctic (Nasdaq Stockholm: BIOA B) enters global license agreement with BMS

TMT | Comment

1Spatial (LSE: SPA) – Wins in the utilities sector for AI-supported apps

Consumer | Comment

Games Workshop Group (LSE: GAW) – returning more cash

Industrials | Comment

Smiths News (LSE: SNWS) confirms long-term contract with Reach

Consumer | Comment

Games Workshop (LSE:GAW) reached final agreement with Amazon

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free